Click on the type of cancer you would like to know more about.
Medullary carcinoma of thyroid
Thyroid - medullary carcinoma; Cancer - thyroid (medullary carcinoma); MTCOverview
Medullary carcinoma of the thyroid is cancer of the thyroid gland that starts in cells that release a hormone called calcitonin. Such cells are called "C" cells.
Review Date: 3/2/2010
Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Â© 1997- 2009 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
The cause of medullary carcinoma of the thyroid (MTC) is unknown.
Unlike other types of thyroid cancer, MTC is less likely to be caused by radiation therapy to the neck given to treat other cancers during childhood.
There are two forms of MTC:
You have an increased risk of this type of cancer if you have:
Other types of thyroid cancer include:
Call your health care provider if you have symptoms of medullary carcinoma of the thyroid.
Treatment involves surgery to remove the thyroid gland and surrounding lymph nodes. Because this is an uncommon tumor, surgery should be performed by a surgeon who is familiar with this type of cancer.
Chemotherapy and radiation do not work very well for this type of cancer. Radiation is used in some patients after surgery. There are a number of new treatments currently being investigated in clinical trials.
Prevention may not be possible. However, being aware of your risk factors, especially your family history, may allow for early diagnosis and treatment. There are some recommendations regarding removing the thyroid gland in people who have a very strong family history of MTC. You should carefully discuss this option with a doctor who is very familiar with the disease.
Approximately 86% of those with medullary carcinoma of the thyroid live at least 5 years after diagnosis. The 10-year survival rate is 65%.
Complications may include:
The health care provider will perform a physical exam. Lymph nodes in the neck may be swollen. Thyroid function tests are usually normal. However, an examination of the thyroid may reveal single or multiple nodules (lumps).
Other tests that may be used to diagnose MTC may include:
Patients with MTC should be checked for certain other tumors, especially pheochromocytoma.